81: Efficacy and safety of AP26113 in ALK+ non-small cell...

81: Efficacy and safety of AP26113 in ALK+ non-small cell lung cancer (NSCLC), including patients with brain metastases

Gettinger, S.N., Bazhenova, L., Salgia, R., Langer, C.J., Gold, K.A., Rosell, R., Shaw, A.T., Weiss, G.J., Narasimhan, N.I., Dorer, D.J., Rivera, V.M., Clackson, T., Haluska, F.G., Camidge, D.R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
87
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/S0169-5002(15)50080-9
Date:
January, 2015
File:
PDF, 48 KB
english, 2015
Conversion to is in progress
Conversion to is failed